141 related articles for article (PubMed ID: 8430017)
21. [Treatment of carcinoid syndrome with a somatostatin analogue].
Döbrönte Z; Stöckert A; Végh G; Varga L
Orv Hetil; 1992 Mar; 133(12):731-4. PubMed ID: 1372969
[TBL] [Abstract][Full Text] [Related]
22. [Familial occurrence of carcinoid of the small intestine].
Lengyel G; Kárteszi M; Vallent K; Makó E; Hídvégi J; Csóti S; Fehér J
Orv Hetil; 1989 Mar; 130(11):573-5. PubMed ID: 2648248
[TBL] [Abstract][Full Text] [Related]
23. [Carcinoid tumors of the intestines: developments in the Netherlands for diagnosis and palliative treatment].
Taal BG; Hoefnagel C; Boot H; de Jong D; Rutgers M
Ned Tijdschr Geneeskd; 1999 Feb; 143(9):445-51. PubMed ID: 10221120
[TBL] [Abstract][Full Text] [Related]
24. Octreotide exerts only acute, but no sustained, effects on MRI enhancement of liver metastases in carcinoid syndrome.
Zomerhuis MT; Hussain SM; Feelders RA; van der Lely AJ; de Herder WW
Neuroendocrinology; 2005; 82(1):41-8. PubMed ID: 16391492
[TBL] [Abstract][Full Text] [Related]
25. [A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].
Del Val A; Ponce J; Talens A; Martí-Bonmati L; Garrigues V; Berenguer J
Rev Esp Enferm Dig; 1991 Mar; 79(3):215-7. PubMed ID: 2043408
[TBL] [Abstract][Full Text] [Related]
26. [Individual therapeutic procedure in metastatic carcinoid of the small intestine].
Barthel A; Leonhardt U; Stöckmann F; Ramadori G
Leber Magen Darm; 1996 May; 26(3):164, 167-9. PubMed ID: 8709831
[TBL] [Abstract][Full Text] [Related]
27. A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review).
Comaru-Schally AM; Schally AV
Int J Oncol; 2005 Feb; 26(2):301-9. PubMed ID: 15645113
[TBL] [Abstract][Full Text] [Related]
28. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
29. Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature.
Leong WL; Pasieka JL
J Surg Oncol; 2002 Mar; 79(3):180-7. PubMed ID: 11870669
[TBL] [Abstract][Full Text] [Related]
30. [Primary and follow-up studies of patients with carcinoid metastases using indium 111 octreotide--rational use of Sandostatin].
Lipp RW; Hammer HF; Passath A; Dobnig H; Ramschak-Schwarzer S; Stiegler C; Leb G; Krejs GJ
Acta Med Austriaca; 1993; 20(1-2):42-4. PubMed ID: 8475679
[TBL] [Abstract][Full Text] [Related]
31. [Prevention of carcinoid tumor crisis].
Kriváchy P; Szabó K; Koiss I; Bálint A
Orv Hetil; 1992 Jan; 133(3):163-6. PubMed ID: 1346472
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcaemia caused by a carcinoid tumour.
Brzozowska MM; Wolmarans L; Conaglen JV
Intern Med J; 2009 Jun; 39(6):415-8. PubMed ID: 19580622
[TBL] [Abstract][Full Text] [Related]
33. Aggressive carcinoid tumors arising in the duodenum, ileum, and rectum with liver metastasis: a report of three cases.
Oka K; Hirai F; Nagakura S; Saito H; Nihei T; Yatabe Y
Hepatogastroenterology; 2008; 55(86-87):1660-3. PubMed ID: 19102364
[TBL] [Abstract][Full Text] [Related]
34. Serotonin in cytologic samples of liver metastases of carcinoid tumors. An immunocytochemical study with a monoclonal antibody.
Wilander E
Acta Cytol; 1985; 29(6):1058-60. PubMed ID: 3866458
[TBL] [Abstract][Full Text] [Related]
35. Tryptophan hydroxylase antibodies used in the diagnosis of carcinoid.
Meyer T; Uher T; Ramadori G; Ringe B; Schwoerer H
Hepatogastroenterology; 1998; 45(23):1522-6. PubMed ID: 9840098
[TBL] [Abstract][Full Text] [Related]
36. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
Christante D; Pommier S; Givi B; Pommier R
Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
[TBL] [Abstract][Full Text] [Related]
37. Multimodality treatment for gastric carcinoid tumor with liver metastases.
Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
[TBL] [Abstract][Full Text] [Related]
38. [Carcinoid tumor with revealed by skin manifestation].
Reichert S; Truchetet F; Cuny JF; Grandidier M
Ann Dermatol Venereol; 1994; 121(6-7):485-8. PubMed ID: 7535513
[TBL] [Abstract][Full Text] [Related]
39. [Intracerebral metastasis of a bronchial carcinoid tumor].
Ohnsmann A; Sachsenheimer W
Neurochirurgia (Stuttg); 1992 Sep; 35(5):160-2. PubMed ID: 1436366
[TBL] [Abstract][Full Text] [Related]
40. Carcinoid syndrome.
Zambrzycki JK; Elliott CG
Nurse Anesth; 1993 Dec; 4(4):198-201. PubMed ID: 7907889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
